F Larra

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

Érick Gamelin, E Danquechin‐Dorval, Y. Dumesnil et al. · Cancer · 1996 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlation Between Uracil and Dihydrouracil Plasma Ratio, Fluorouracil (5-FU) Pharmacokinetic Parameters, and Tolerance in Patients With Advanced Colorectal Cancer: A Potential Interest for Predicting 5-FU Toxicity and Determining Optimal 5-FU Dosage

Érick Gamelin, M. Boisdron‐Celle, Véronique Guerin‐Meyer et al. · Journal of Clinical Oncology · 1999 · 205 citations

Medicine, Pharmacokinetics, Pharmacology +17

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

Érick Gamelin, M. Boisdron‐Celle, R. Delva et al. · Journal of Clinical Oncology · 1998 · 159 citations

Medicine, Oncology, Pharmacology +17

Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.

Jean-Pierre Muratet, A Daver, J Minier et al. · PubMed · 1998 · 116 citations

Medicine, Nuclear Medicine, Radiology +17

Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.

Érick Gamelin, Anne Le Bouil, M. Boisdron‐Celle et al. · PubMed · 1997 · 82 citations

Medicine, Pharmacokinetics, Pharmacology +15